Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
Condition(s):Chronic Hepatitis C Virus InfectionLast Updated:February 10, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Chronic Hepatitis C Virus InfectionLast Updated:February 10, 2010Unknown status
Condition(s):HealthyLast Updated:May 27, 2020Completed
Condition(s):HealthyLast Updated:January 9, 2019Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:May 13, 2016Withdrawn
Condition(s):Coronavirus Infection; SARS-CoV 2Last Updated:August 19, 2020Recruiting
Condition(s):HealthyLast Updated:August 4, 2015Completed
Condition(s):HIV-1-infectionLast Updated:February 12, 2021Active, not recruiting
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:December 8, 2020Recruiting
Condition(s):Leukaemia (Acute); Leukaemia (Chronic); Leukaemia (Acute Myeloid); Leukaemia (Acute Lymphoblastic); Leukaemia (Acute Promyelocytic)Last Updated:September 7, 2018Completed
Condition(s):Anal Intraepithelial Neoplasia; High Grade Squamous Intraepithelial Neoplasia; HIV Positivity; Human Papillomavirus-16 Positive; Human Papillomavirus-18 PositiveLast Updated:February 25, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.